Clinical trial
SINGapore SoniCracker IntraVascular Lithotripsy (SING IVL) Study
NCT07259239 is registered in ClinicalTrials.gov with National Heart Centre Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SINGapore SoniCracker IntraVascular Lithotripsy (SING IVL) Study
- Lead sponsor
- National Heart Centre Singapore
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 30, 2025
- Completion date
- July 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.